Keyphrases
Confidence Interval
100%
Cancer Outcomes
100%
Regulatory T Cells
100%
Common Variation
100%
Ovarian Cancer
100%
Large-scale Assessment
100%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
60%
SNP
40%
TGFBR3
40%
Clear Cell
40%
Treg
40%
STAT5A
40%
Ovarian Cancer Survival
40%
IL2RA
40%
Rs231775
40%
Solid Tumors
20%
Patient Survival
20%
Genotype
20%
Genetic Variation
20%
Malignancy
20%
Interleukin-10
20%
Overall Survival
20%
Single nucleotide Polymorphism
20%
Autoimmune Disease
20%
Associated Genes
20%
European Ancestry
20%
Improved Survival
20%
Population Stratification
20%
CD28
20%
Aging Studies
20%
Endometrioid
20%
Epithelial Ovarian Cancer
20%
Forkhead Box P3 (FOXP3)
20%
Oral Contraceptive Use
20%
Amino Acid Variation
20%
Interleukin-6 Receptor (IL-6R)
20%
Cancer Association
20%
Interleukin-15 (IL-15)
20%
Indoleamine 2,3-dioxygenase 1 (IDO1)
20%
Endometrioid Carcinoma
20%
Clear Cell Carcinoma
20%
Tag Single nucleotide Polymorphism (tSNP)
20%
IL-23R
20%
Transforming Growth factor-β1 (TGF-β1)
20%
IL10RA
20%
Transforming Growth factor-β2 (TGF-β2)
20%
IL23A
20%
Regulatory T Cell(Treg)
20%
Mucinous Carcinoma
20%
High-grade Serous
20%
MAP3K8
20%
LGALS1
20%
TGFBR1
20%
Site Populations
20%
Endometrioid Ovarian Cancer
20%
LGALS9
20%
Medicine and Dentistry
Single Nucleotide Polymorphism
100%
Ovarian Cancer
100%
Regulatory T Cell
100%
Clear Cell
50%
Krukenberg Tumor
50%
Ovarian Cancer Survival
50%
Solid Malignant Neoplasm
25%
Cancer
25%
Overall Survival
25%
Allele
25%
Population Stratification
25%
Amino Acid
25%
Genetic Variation
25%
Oral Contraceptive Use
25%
Mucinous Carcinoma
25%
Endometrioid Carcinoma
25%
Clear Cell Carcinoma
25%
Biochemistry, Genetics and Molecular Biology
Regulatory T Cell
100%
Single Nucleotide Polymorphism
40%
Single-Nucleotide Polymorphism
40%
Cancer Survival
40%
IL2RA
40%
Allele
20%
Genotyping
20%
Overall Survival
20%
Genetic Variation
20%
Amino Acids
20%
CD28
20%
TGFBR3
20%
STAT5A
20%
Oral Contraceptive Use
20%
STAT5B
20%
FOXP3
20%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Cytotoxic T Lymphocyte Antigen 4
60%
Ovary Carcinoma
40%
Cancer Survival
40%
Overall Survival
20%
Amino Acid
20%
Solid Malignant Neoplasm
20%
Oral Contraceptive
20%
Clear Cell Carcinoma
20%
Colloid Carcinoma
20%
Endometrioid Carcinoma
20%